Cerebrovascular disease in central nervous system infections

Seminars in Neurology

Volumn 31, Issue 3, 2011, Pages 286-306

  Chow, Felicia C ^a,b   Marra, Christina M ^c   Cho, Tracey A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

central nervous system; cerebrovascular; infection; meningitis; Stroke; vasculitis; vasculopathy

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT; ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUCONAZOLE; FLUCYTOSINE; IMMUNOSUPPRESSIVE AGENT; PENICILLIN G; PROTEIN S; TUBERCULOSTATIC AGENT; VORICONAZOLE;

ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACTERIAL MENINGITIS; BACTERIUM; BRAIN BIOPSY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN VASCULITIS; BRAIN VASOSPASM; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBRAL COCCIDIOMYCOSIS; CEREBRAL MUCORMYCOSIS; CEREBROVASCULAR DISEASE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; ENDOTHELIAL DYSFUNCTION; FUNGUS; GOLD STANDARD; HERPES ZOSTER; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCOAGULABILITY; INFLAMMATION; INTRACRANIAL PRESSURE; INVASIVE ASPERGILLOSIS; MENINGITIS; MUCORMYCOSIS; NEUROCYSTICERCOSIS; NEUROIMAGING; NEUROPATHOLOGY; NEUROSYPHILIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OPPORTUNISTIC INFECTION; PARASITE; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; PYOGENIC BACTERIAL MENINGITIS; RECOMMENDED DRUG DOSE; STROKE; SUBARACHNOID CYSTICERCOSIS; SYPHILITIC MENINGITIS; TAENIA SOLIUM; THORAX RADIOGRAPHY; TREPONEMA PALLIDUM; TUBERCULOSIS; TUBERCULOUS MENINGITIS; VARICELLA ZOSTER VIRUS; VIRUS; ZYGOMYCETES;

ANIMALS; BACTERIA; CENTRAL NERVOUS SYSTEM INFECTIONS; CEREBROVASCULAR DISORDERS; FUNGI; HUMANS; PARASITES; VIRUSES;

EID: 80053536484     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1287658     Document Type: Article

References (256)

1. Kiechl S, Egger G, Mayr M et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001 103 8 1064-1070 (Pubitemid 32200178)
2. Elkind M SV, Ramakrishnan P, Moon Y P. et al. Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol 2010 67 1 33-38
3. Grau A J., Brandt T. Do multiple chronic infections increase the risk of stroke?: the infectious burden concept. Arch Neurol 2010 67 1 16-17
4. Thigpen M C., Whitney C G., Messonnier N E. et al, Emerging Infections Programs Network. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011 364 21 2016-2025
5. Durand M L., Calderwood S B., Weber D J. et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993 328 1 21-28 (Pubitemid 23011467)
6. Kastenbauer S, Pfister H W. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003 126 Pt 5 1015-1025 (Pubitemid 36522945)
7. Pfister H W., Borasio G D., Dirnagl U, Bauer M, Einhäupl K M. Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992 42 8 1497-1504
8. Weststrate W, Hijdra A, de Gans J. Brain infarcts in adults with bacterial meningitis. Lancet 1996 347 8998 399 (Pubitemid 26046120)
9. van de Beek D, de Gans J, Tunkel A R., Wijdicks E FM. Community-acquired bacterial meningitis in adults. N Engl J Med 2006 354 1 44-53 (Pubitemid 43048950)
10. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma J B., Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004 351 18 1849-1859
11. Klein M, Koedel U, Kastenbauer S et al. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis: past as prologue: delayed stroke as a parainfectious process of bacterial meningitis? Neurology 2010 75 2 193-194, author reply 193194
12. van de Beek D, Patel R, Wijdicks E FM. Meningococcal meningitis with brainstem infarction. Arch Neurol 2007 64 9 1350-1351 (Pubitemid 47403095)
13. Schut E S., Brouwer M C., de Gans J, Florquin S, Troost D, van de Beek D. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 2009 73 23 1988-1995
14. Levi M, van der Poll T, Büller H R. Bidirectional relation between inflammation and coagulation. Circulation 2004 109 22 2698-2704 (Pubitemid 38737913)
15. Vergouwen M DI, Schut E S., Troost D, van de Beek D. Diffuse cerebral intravascular coagulation and cerebral infarction in pneumococcal meningitis. Neurocrit Care 2010 13 2 217-227
16. Klein M, Koedel U, Kastenbauer S et al. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis: past as prologue: delayed stroke as a parainfectious process of bacterial meningitis? Neurology 2010 75 2 193 author reply 193-194
17. Czartoski T, Hallam D, Lacy J M., Chun M R., Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry 2005 76 2 256-259 (Pubitemid 40143719)
18. Pugin D, Copin J C., Goodyear M C., Landis T, Gasche Y. Persisting vasculitis after pneumococcal meningitis. Neurocrit Care 2006 4 3 237-240 (Pubitemid 43998018)
19. Tunkel A R., Hartman B J., Kaplan S L. et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004 39 9 1267-1284 (Pubitemid 39458512)
20. de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002 347 20 1549-1556 (Pubitemid 35315835)
21. van de Beek D, Farrar J J., de Gans J et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010 9 3 254-263
22. Brouwer M C., Heckenberg S G., de Gans J, Spanjaard L, Reitsma J B., van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010 75 17 1533-1539
23. Brouwer M C., McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010 9 CD004405
24. van de Beek D, Weisfelt M, de Gans J, Tunkel A R., Wijdicks E FM. Drug insight: adjunctive therapies in adults with bacterial meningitis. Nat Clin Pract Neurol 2006 2 9 504-516 (Pubitemid 44275726)
25. World Health Organization. Global tuberculosis control 2010. Available at: http://www.who.int/tb/publications/global-report/2010/en/index.html Accessed June 1, 2011
26. Christensen A S., Andersen A B., Thomsen V O., Andersen P H., Johansen I S. Tuberculous meningitis in Denmark: a review of 50 cases. BMC Infect Dis 2011 11 47
27. Centers for Disease Control and Prevention. Reported tuberculosis in the United States 2009. Available at: http://www.cdc.gov/tb/statistics/reports/2009/ pdf/report2009.pdf Accessed June 1, 2011
28. Ogawa S K., Smith M A., Brennessel D J., Lowy F D. Tuberculous meningitis in an urban medical center. Medicine (Baltimore) 1987 66 4 317-326 (Pubitemid 17143603)
29. Kent S J., Crowe S M., Yung A, Lucas C R., Mijch A M. Tuberculous meningitis: a 30-year review. Clin Infect Dis 1993 17 6 987-994 (Pubitemid 23358742)
30. Girgis N I., Sultan Y, Farid Z et al. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 1998 58 1 28-34 (Pubitemid 28071406)
31. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, British Infection Society. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009 59 3 167-187
32. Dastur D K., Manghani D K., Udani P M. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am 1995 33 4 733-752
33. Katrak S M. Vasculitis and stroke due to tuberculosis. In: Caplan L R. ed. Uncommon Causes of Stroke. 2nd ed. New York Cambridge University Press 2008 41-45
34. Lammie G A., Hewlett R H., Schoeman J F., Donald P R. Tuberculous cerebrovascular disease: a review. J Infect 2009 59 3 156-166
35. Misra U K., Kalita J, Maurya P K. Stroke in tuberculous meningitis. J Neurol Sci 2011 303 1-2 22-30
36. Shukla R, Abbas A, Kumar P, Gupta R K., Jha S, Prasad K N. Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging. J Infect 2008 57 4 298-306
37. Donald P R., Schoeman J F. Tuberculous meningitis. N Engl J Med 2004 351 17 1719-1720 (Pubitemid 39383206)
38. Kalita J, Misra U K., Nair P P. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis 2009 18 4 251-258
39. Dalal P M., Dalal K P. Subcortical and lacunar infarctions in neurotuberculosis. In: Donnan G A. Norrving B Bamford J M. Bogousslvsky J eds. Lacunar and Other Subcortical Infarctions. New York Oxford University Press 1995 219-230
40. Rich A R., McCordock H A. The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hosp 1933 53 5-37
41. Brown E, Gray F. Bacterial infections. In: Love S Louis D N. Ellison D W. eds. Greenfield's Neuropathology. 8th ed. London Hodder Arnold 2008 1391-1445
42. Dalal P M. Observations on the involvement of cerebral vessels in tuberculous meningitis in adults. Adv Neurol 1979 25 149-159
43. Rojas-Echeverri L A., Soto-Hernández J L., Garza S et al. Predictive value of digital subtraction angiography in patients with tuberculous meningitis. Neuroradiology 1996 38 1 20-24
44. Sütla P N., Unal A, Forta H, Senol S, Kirba D. Tuberculous meningitis in adults: review of 61 cases. Infection 2003 31 6 387-391 (Pubitemid 38005368)
45. Jeren T, Beus I. Characteristics of cerebrospinal fluid in tuberculous meningitis. Acta Cytol 1982 26 5 678-680 (Pubitemid 12003594)
46. Thwaites G E., Chau T T., Stepniewska K et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002 360 9342 1287-1292 (Pubitemid 35284620)
47. Zuger A. Tuberculosis. In: Scheld W M. Whitley R J. Marra C M. eds. Infections of the Central Nervous System. 3rd ed. Philadelphia Lippincott Williams and Wilkins 2004 441-459
48. Verdon R, Chevret S, Laissy J P., Wolff M. Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 1996 22 6 982-988 (Pubitemid 26260599)
49. Thwaites G E., Chau T T., Farrar J J. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 2004 42 1 378-379 (Pubitemid 38082750)
50. Thwaites G E., Caws M, Chau T T. et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 2004 42 3 996-1002 (Pubitemid 38332816)
51. Pai M, Flores L L., Pai N, Hubbard A, Riley L W., Colford J M. Jr. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003 3 10 633-643 (Pubitemid 37210227)
52. Hsieh F Y., Chia L G., Shen W C. Locations of cerebral infarctions in tuberculous meningitis. Neuroradiology 1992 34 3 197-199
53. Nair P P., Kalita J, Kumar S, Misra U K. MRI pattern of infarcts in basal ganglia region in patients with tuberculous meningitis. Neuroradiology 2009 51 4 221-225
54. Greitz T. Angiography in tuberculous meningitis. Acta Radiol Diagn (Stockh) 1964 2 369-378
55. Lehrer H. The angiographic triad in tuberculous meningitis. A radiographic and clinicopathologic correlation. Radiology 1966 87 5 829-835
56. Mathew N T., Abraham J, Chandy J. Cerebral angiographic features in tuberculous meningitis. Neurology 1970 20 10 1015-1023
57. Koh S B., Kim B J., Park M H., Yu S W., Park K W., Lee D H. Clinical and laboratory characteristics of cerebral infarction in tuberculous meningitis: a comparative study. J Clin Neurosci 2007 14 11 1073-1077 (Pubitemid 47588940)
58. Misra U K., Kalita J, Roy A K., Mandal S K., Srivastava M. Role of clinical, radiological, and neurophysiological changes in predicting the outcome of tuberculous meningitis: a multivariable analysis. J Neurol Neurosurg Psychiatry 2000 68 3 300-303 (Pubitemid 30248702)
59. Berenguer J, Moreno S, Laguna F et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992 326 10 668-672
60. Dubé M P., Holtom P D., Larsen R A. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 1992 93 5 520-524
61. Porkert M T., Sotir M, Parrott-Moore P, Blumberg H M. Tuberculous meningitis at a large inner-city medical center. Am J Med Sci 1997 313 6 325-331 (Pubitemid 27249086)
62. Yechoor V K., Shandera W X., Rodriguez P, Cate T R. Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Arch Intern Med 1996 156 15 1710-1716 (Pubitemid 26287128)
63. Schutte C M. Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis. Infection 2001 29 4 213-217
64. van der Weert E M., Hartgers N M., Schaaf H S. et al. Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 2006 25 1 65-69 (Pubitemid 43361479)
65. Jarvis J N., Meintjes G, Williams A, Brown Y, Crede T, Harrison T S. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis 2010 10 67
66. Katrak S M., Shembalkar P K., Bijwe S R., Bhandarkar L D. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 2000 181 1-2 118-126
67. Thwaites G E., Duc Bang N, Huy Dung N et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. J Infect Dis 2005 192 12 2134-2141 (Pubitemid 41779213)
68. Jones B E., Young S M., Antoniskis D, Davidson P T., Kramer F, Barnes P F. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993 148 5 1292-1297
69. American Thoracic Society CDC Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003 52 RR-11 1-77
70. Thwaites G E., Nguyen D B., Nguyen H D. et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004 351 17 1741-1751
71. Prasad K, Singh M B. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008 1 CD002244
72. Marais S, Pepper D J., Schutz C, Wilkinson R J., Meintjes G. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS ONE 2011 6 5 e20077
73. Teoh R, Humphries M J., O'Mahony G. Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature. Q J Med 1987 63 241 449-460 (Pubitemid 17084763)
74. Narita M, Ashkin D, Hollender E S., Pitchenik A E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998 158 1 157-161 (Pubitemid 28337174)
75. Pepper D J., Marais S, Maartens G et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009 48 11 e96-e107
76. Thwaites G E., Macmullen-Price J, Tran T H. et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007 6 3 230-236 (Pubitemid 46228070)
77. Misra U K., Kalita J, Nair P P. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci 2010 293 1-2 12-17
78. CDC. Syphilis. Sexually Transmitted Diseases 2009. Available at: http://www.cdc.gov/std/stats09/syphilis.htm Accessed May 25, 2011
79. Lukehart S A., Hook E W. III, Baker-Zander S A., Collier A C., Critchlow C W., Handsfield H H. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988 109 11 855-862 (Pubitemid 19000024)
80. Rolfs R T., Joesoef M R., Hendershot E F. et al, The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997 337 5 307-314 (Pubitemid 27318992)
81. Merrit H H., Adams R D., Solomon H C. Neurosyphilis. New York Oxford University Press 1946
82. Burke J M., Schaberg D R. Neurosyphilis in the antibiotic era. Neurology 1985 35 9 1368-1371 (Pubitemid 15021608)
83. Stokes J H., Beerman H, Ingraham N R. Modern Clinical Sphilology: Diagnosis, Treatment, Case Study. Philadelphia WB Saunders 1944
84. Timmermans M, Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry 2004 75 12 1727-1730 (Pubitemid 39611474)
85. Musher D M. Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis 1991 163 6 1201-1206
86. Holmes M D., Brant-Zawadzki M M., Simon R P. Clinical features of meningovascular syphilis. Neurology 1984 34 4 553-556 (Pubitemid 14127333)
87. Harriman D GF. Bacterial infections of the central nervous system. In: Blackwood W Corsellis J AN eds. Greenfield's Neuropathology. 3rd ed. Chicago Yearbook Medical Publishers 1976 238-268
88. Vatz K A., Scheibel R L., Keiffer S A., Ansari K A. Neurosyphilis and diffuse cerebral angiopathy: a case report. Neurology 1974 24 5 472-476
89. Winkelman N W., Eckel J L. Productive endarteritis of the small cortical vessels in severe toxemias. Brain 1927 50 34 608-623
90. Davis L E., Schmitt J W. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 1989 25 1 50-55 (Pubitemid 19032842)
91. Workowski K A., Berman S M., Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006 55 RR-11 1-94
92. Jaffe H W., Larsen S A., Peters M, Jove D F., Lopez B, Schroeter A L. Tests for treponemal antibody in CSF. Arch Intern Med 1978 138 2 252-255 (Pubitemid 9039635)
93. Simon R P. Neurosyphilis. Arch Neurol 1985 42 6 606-613 (Pubitemid 15033103)
94. Marra C M., Maxwell C L., Collier A C., Robertson K R., Imrie A. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007 7 37
95. Berry C D., Hooton T M., Collier A C., Lukehart S A. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987 316 25 1587-1589 (Pubitemid 17083597)
96. Johns D R., Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987 316 25 1569-1572 (Pubitemid 17083594)
97. Katz D A., Berger J R., Duncan R C. Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. Arch Neurol 1993 50 3 243-249 (Pubitemid 23069607)
98. Centers for Disease Control and Prevention (CDC). Symptomatic early neurosyphilis among HIV-positive men who have sex with menfour cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 2007 56 25 625-628
99. Chang C C., Leslie D E., Spelman D et al. Symptomatic and asymptomatic early neurosyphilis in HIV-infected men who have sex with men: a retrospective case series from 2000 to 2007. Sex Health 2011 8 2 207-213
100. Bucher J B., Golden M R., Heald A E., Marra C M. Stroke in a patient with human immunodeficiency virus and syphilis treated with penicillin and antiretroviral therapy. Sex Transm Dis 2010 November 30 (Epub ahead of print)
101. Marra C M., Maxwell C L., Smith S L. et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004 189 3 369-376 (Pubitemid 38210572)
102. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. 2008. Available at: http://AIDSinfo.nih.gov Accessed May 28, 2009
103. Ghanem K G., Erbelding E J., Wiener Z S., Rompalo A M. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007 83 2 97-101 (Pubitemid 46713595)
104. Kelley R E., Minagar A, Kelley B J., Brunson R. Trancranial Doppler monitoring of response to therapy for meningovascular syphilis. J Neuroimaging 2003 13 1 85-87 (Pubitemid 36026208)
105. Davis L E., Graham G D. Neurosyphilis and stroke. In: Caplan L R. ed. Uncommon Causes of Stroke. 2nd ed. New York Cambridge University Press 2008 35-39
106. Askalan R, Laughlin S, Mayank S et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001 32 6 1257-1262 (Pubitemid 32530402)
107. Lanthier S, Armstrong D, Domi T, deVeber G. Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology 2005 64 4 660-663 (Pubitemid 40261894)
108. Miravet E, Danchaivijitr N, Basu H, Saunders D E., Ganesan V. Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol 2007 49 6 417-422 (Pubitemid 46845373)
109. Manco-Johnson M J., Nuss R, Key N et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996 128 3 319-323 (Pubitemid 26087529)
110. Massano J, Ferreira D, Toledo T, Mansilha A, Azevedo E, Carvalho M. Stroke and multiple peripheral thrombotic events in an adult with varicella. Eur J Neurol 2008 15 10 e90-e91
111. Josephson C, Nuss R, Jacobson L et al. The varicella-autoantibody syndrome. Pediatr Res 2001 50 3 345-352 (Pubitemid 32801959)
112. Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep 2009 9 6 430-434
113. Reshef E, Greenberg S B., Jankovic J. Herpes zoster ophthalmicus followed by contralateral hemiparesis: report of two cases and review of literature. J Neurol Neurosurg Psychiatry 1985 48 2 122-127 (Pubitemid 15063905)
114. Hilt D C., Buchholz D, Krumholz A, Weiss H, Wolinsky J S. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol 1983 14 5 543-553 (Pubitemid 14239723)
115. Nagel M A., Cohrs R J., Mahalingam R et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008 70 11 853-860 (Pubitemid 351367506)
116. Gray F, Bélec L, Lescs M C. et al. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994 117 Pt 5 987-999 (Pubitemid 24350534)
117. Nagel M A., Mahalingam R, Cohrs R J., Gilden D. Virus vasculopathy and stroke: an under-recognized cause and treatment target. Infect Disord Drug Targets 2010 10 2 105-111
118. Nagel M A., Forghani B, Mahalingam R et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007 68 13 1069-1073 (Pubitemid 46569144)
119. Katchanov J, Siebert E, Klingebiel R, Endres M. Infectious vasculopathy of intracranial large- and medium-sized vessels in neurological intensive care unit: a clinico-radiological study. Neurocrit Care 2010 12 3 369-374
120. Schmidbauer M, Budka H, Pilz P, Kurata T, Hondo R. Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain 1992 115 Pt 2 383-398
121. Kleinschmidt-DeMasters B K., Amlie-Lefond C, Gilden D H. The patterns of varicella zoster virus encephalitis. Hum Pathol 1996 27 9 927-938 (Pubitemid 26304572)
122. Ruppenthal M. Changes of the central nervous system in herpes zoster. Acta Neuropathol 1980 52 1 59-68 (Pubitemid 10011159)
123. Gilden D H., Kleinschmidt-DeMasters B K., LaGuardia J J., Mahalingam R, Cohrs R J. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000 342 9 635-645 (Pubitemid 30118417)
124. Gilden D, Cohrs R J., Mahalingam R, Nagel M A. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009 8 8 731-740
125. Newsome S D., Nath A. Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol 2009 15 3 288-291
126. Oxman M N., Levin M J., Johnson G R. et al, Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005 352 22 2271-2284
127. Triant V A., Lee H, Hadigan C, Grinspoon S K. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007 92 7 2506-2512 (Pubitemid 47037350)
128. Currier J S., Taylor A, Boyd F et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003 33 4 506-512 (Pubitemid 36886080)
129. Friis-Mller N, Sabin C A., Weber R et al, Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003 349 21 1993-2003
130. Berger J R., Harris J O., Gregorios J, Norenberg M. Cerebrovascular disease in AIDS: a case-control study. AIDS 1990 4 3 239-244 (Pubitemid 20147002)
131. Cole J W., Pinto A N., Hebel J R. et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004 35 1 51-56 (Pubitemid 38057589)
132. Engstrom J W., Lowenstein D H., Bredesen D E. Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am J Med 1989 86 5 528-532 (Pubitemid 19121250)
133. Pinto A N. AIDS and cerebrovascular disease. Stroke 1996 27 3 538-543 (Pubitemid 26081455)
134. Anders K H., Guerra W F., Tomiyasu U, Verity M A., Vinters H V. The neuropathology of AIDS. UCLA experience and review. Am J Pathol 1986 124 3 537-558 (Pubitemid 16029458)
135. Mizusawa H, Hirano A, Llena J F., Shintaku M. Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1988 76 5 451-457
136. Connor M D., Lammie G A., Bell J E., Warlow C P., Simmonds P, Brettle R D. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke 2000 31 9 2117-2126
137. Gray F, Gherardi R, Scaravilli F. The neuropathology of the acquired immune deficiency syndrome (AIDS). A review. Brain 1988 111 Pt 2 245-266
138. Evers S, Nabavi D, Rahmann A, Heese C, Reichelt D, Husstedt I W. Ischaemic cerebrovascular events in HIV infection: a cohort study. Cerebrovasc Dis 2003 15 3 199-205 (Pubitemid 36351206)
139. Corral I, Quereda C, Moreno A et al. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Cerebrovasc Dis 2009 27 6 559-563
140. Berger J R. AIDS and stroke risk. Lancet Neurol 2004 3 4 206-207 (Pubitemid 38373657)
141. Ovbiagele B, Nath A. Increasing incidence of ischemic stroke in patients with HIV infection. Neurology 2011 January 19 (Epub ahead of print)
142. Chetty R. Vasculitides associated with HIV infection. J Clin Pathol 2001 54 4 275-278 (Pubitemid 32270009)
143. Calabrese L H., Estes M, Yen-Lieberman B et al. Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis Rheum 1989 32 5 569-576 (Pubitemid 19146697)
144. Calabrese L H. Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am 1991 17 1 131-147
145. Anders K H., Latta H, Chang B S., Tomiyasu U, Quddusi A S., Vinters H V. Lymphomatoid granulomatosis and malignant lymphoma of the central nervous system in the acquired immunodeficiency syndrome. Hum Pathol 1989 20 4 326-334 (Pubitemid 19102123)
146. Calabrese L H. Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease. Clin Exp Rheumatol 2004 22 6, Suppl 36 S87-S93
147. Nogueras C, Sala M, Sasal M et al. Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with human immunodeficiency virus. Arch Neurol 2002 59 3 468-473 (Pubitemid 34208159)
148. Melica G, Brugieres P, Lascaux A S., Levy Y, Lelivre J D. Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era. J Med Virol 2009 81 4 578-581
149. Frank Y, Lim W, Kahn E, Farmer P, Gorey M, Pahwa S. Multiple ischemic infarcts in a child with AIDS, varicella zoster infection, and cerebral vasculitis. Pediatr Neurol 1989 5 1 64-67 (Pubitemid 19074485)
150. Yankner B A., Skolnik P R., Shoukimas G M., Gabuzda D H., Sobel R A., Ho D D. Cerebral granulomatous angiitis associated with isolation of human T-lymphotropic virus type III from the central nervous system. Ann Neurol 1986 20 3 362-364 (Pubitemid 16018523)
151. Bhagavati S, Choi J. Rapidly progressive cerebrovascular stenosis and recurrent strokes followed by improvement in HIV vasculopathy. Cerebrovasc Dis 2008 26 4 449-452
152. Gillams A R., Allen E, Hrieb K, Venna N, Craven D, Carter A P. Cerebral infarction in patients with AIDS. AJNR Am J Neuroradiol 1997 18 8 1581-1585 (Pubitemid 30413977)
153. Vinters H V., Guerra W F., Eppolito L, Keith P E. III. Necrotizing vasculitis of the nervous system in a patient with AIDS-related complex. Neuropathol Appl Neurobiol 1988 14 5 417-424
154. Scaravilli F, Daniel S E., Harcourt-Webster N, Guiloff R J. Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome. A possible role for human immunodeficiency virus. Arch Pathol Lab Med 1989 113 2 192-195 (Pubitemid 19053726)
155. Burns D K. The neuropathology of pediatric acquired immunodeficiency syndrome. J Child Neurol 1992 7 4 332-346
156. Park Y D., Belman A L., Kim T S. et al. Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol 1990 28 3 303-311 (Pubitemid 20292615)
157. Dubrovsky T, Curless R, Scott G et al. Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology 1998 51 2 560-565 (Pubitemid 28406338)
158. Martínez-Longoria C A., Morales-Aguirre J J., Villalobos-Acosta C P., Gómez-Barreto D, Cashat-Cruz M. Occurrence of intracerebral aneurysm in an HIV-infected child: a case report. Pediatr Neurol 2004 31 2 130-132 (Pubitemid 39070192)
159. Mazzoni P, Chiriboga C A., Millar W S., Rogers A. Intracerebral aneurysms in human immunodeficiency virus infection: case report and literature review. Pediatr Neurol 2000 23 3 252-255
160. Patsalides A D., Wood L V., Atac G K., Sandifer E, Butman J A., Patronas N J. Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings. AJR Am J Roentgenol 2002 179 4 999-1003
161. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 2000 31 3 374-379 (Pubitemid 30161358)
162. Tipping B, de Villiers L, Candy S, Wainwright H. Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch Neurol 2006 63 11 1640-1642 (Pubitemid 44748809)
163. Tipping B, de Villiers L, Wainwright H, Candy S, Bryer A. Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry 2007 78 12 1320-1324 (Pubitemid 350221410)
164. Qureshi A I., Janssen R S., Karon J M. et al. Human immunodeficiency virus infection and stroke in young patients. Arch Neurol 1997 54 9 1150-1153 (Pubitemid 27396483)
165. Mochan A, Modi M, Modi G. Stroke in black South African HIV-positive patients: a prospective analysis. Stroke 2003 34 1 10-15 (Pubitemid 36070791)
166. Mochan A, Modi M, Modi G. Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection. J Neurol Neurosurg Psychiatry 2005 76 10 1455-1456 (Pubitemid 41360992)
167. Ortiz G, Koch S, Romano J G., Forteza A M., Rabinstein A A. Mechanisms of ischemic stroke in HIV-infected patients. Neurology 2007 68 16 1257-1261 (Pubitemid 46625970)
168. Stein J H. Dyslipidemia in the era of HIV protease inhibitors. Prog Cardiovasc Dis 2003 45 4 293-304 (Pubitemid 36293025)
169. Walli R, Herfort O, Michl G M. et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998 12 15 F167-F173 (Pubitemid 28479266)
170. Périard D, Telenti A, Sudre P et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 1999 100 7 700-705 (Pubitemid 29383638)
171. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS 2003 17 Suppl 1 S141-S148 (Pubitemid 36667790)
172. Chen D, Misra A, Garg A. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2002 87 11
173. Saif M W., Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001 15 6 311-320 (Pubitemid 32554157)
174. Fantoni M, Del Borgo C, Autore C. Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2003 17 Suppl 1 S162-S169 (Pubitemid 36667793)
175. Bozzette S A., Ake C F., Tam H K. et al. Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2008 47 3 338-341 (Pubitemid 351619420)
176. Currier J S., Kendall M A., Zackin R et al, AACTG 5078 Study Team. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS 2005 19 9 927-933 (Pubitemid 40834935)
177. El-Sadr W M., Lundgren J D., Neaton J D. et al, Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+count-guided interruption of antiretroviral treatment. N Engl J Med 2006 355 22 2283-2296
178. Mercié P, Thiébaut R, Lavignolle V et al. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med 2002 34 1 55-63 (Pubitemid 34454422)
179. Seaberg E C., Benning L, Sharrett A R. et al. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke 2010 41 10 2163-2170
180. Denning D W. Invasive aspergillosis. Clin Infect Dis 1998 26 4 781-803 quiz 804-805
181. Torre-Cisneros J, Lopez O L., Kusne S et al. CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1993 56 2 188-193 (Pubitemid 23075414)
182. Walsh T J., Hier D B., Caplan L R. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985 18 5 574-582 (Pubitemid 16258093)
183. Hori A, Kami M, Kishi Y, Machida U, Matsumura T, Kashima T. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients. J Hosp Infect 2002 50 3 175-182 (Pubitemid 37554871)
184. Kleinschmidt-DeMasters B K. Central nervous system aspergillosis: a 20-year retrospective series. Hum Pathol 2002 33 1 116-124
185. Pongbhaesaj P, Dejthevaporn C, Tunlayadechanont S, Witoonpanich R, Sungkanuparph S, Vibhagool A. Aspergillosis of the central nervous system: a catastrophic opportunistic infection. Southeast Asian J Trop Med Public Health 2004 35 1 119-125 (Pubitemid 38860067)
186. Lin S J., Schranz J, Teutsch S M. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001 32 3 358-366 (Pubitemid 32173620)
187. Denning D W. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996 23 3 608-615 (Pubitemid 26304513)
188. Schwartz S, Thiel E. Update on the treatment of cerebral aspergillosis. Ann Hematol 2004 83 Suppl 1 S42-S44
189. Sood S, Sharma R, Gupta S, Pathak D, Rishi S. Neuroaspergillosis in an immunocompetent patient. Indian J Med Microbiol 2007 25 1 67-69 (Pubitemid 46466027)
190. Martins H S., da Silva T R., Scalabrini-Neto A, Velasco I T. Cerebral vasculitis caused by Aspergillus simulating ischemic stroke in an immunocompetent patient. J Emerg Med 2010 38 5 597-600
191. Murthy J M., Sundaram C, Prasad V S., Purohit A K., Rammurti S, Laxmi V. Aspergillosis of central nervous system: a study of 21 patients seen in a university hospital in south India. J Assoc Physicians India 2000 48 7 677-681
192. Ho C L., Deruytter M J. CNS aspergillosis with mycotic aneurysm, cerebral granuloma and infarction. Acta Neurochir (Wien) 2004 146 8 1-6
193. Hagensee M E., Bauwens J E., Kjos B, Bowden R A. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994 19 3 402-408 (Pubitemid 24286941)
194. Hummel M, Spiess B, Kentouche K et al. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol 2006 44 11 3989-3993 (Pubitemid 44737240)
195. Kami M, Shirouzu I, Mitani K et al. Early diagnosis of central nervous system aspergillosis with combination use of cerebral diffusion-weighted echo-planar magnetic resonance image and polymerase chain reaction of cerebrospinal fluid. Intern Med 1999 38 1 45-48
196. Wheat L J. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 2003 5 4 158-166 (Pubitemid 41709864)
197. Musher B, Fredricks D, Leisenring W, Balajee S A., Smith C, Marr K A. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004 42 12 5517-5522 (Pubitemid 39664330)
198. Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (13)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008 46 3 1009-1013 (Pubitemid 351379994)
199. Viscoli C, Machetti M, Gazzola P et al. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol 2002 40 4 1496-1499 (Pubitemid 34279924)
200. Miaux Y, Ribaud P, Williams M et al. MR of cerebral aspergillosis in patients who have had bone marrow transplantation. AJNR Am J Neuroradiol 1995 16 3 555-562
201. Gabelmann A, Klein S, Kern W et al. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol 2007 14 5 548-555 (Pubitemid 46587844)
202. Hurst R W., Judkins A, Bolger W, Chu A, Loevner L A. Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation. AJNR Am J Neuroradiol 2001 22 5 858-863 (Pubitemid 32436227)
203. Endo T, Tominaga T, Konno H, Yoshimoto T. Fatal subarachnoid hemorrhage, with brainstem and cerebellar infarction, caused by Aspergillus infection after cerebral aneurysm surgery: case report. Neurosurgery 2002 50 5 1147-1150 discussion 1150-1151
204. Iihara K, Makita Y, Nabeshima S, Tei T, Keyaki A, Nioka H. Aspergillosis of the central nervous system causing subarachnoid hemorrhage from mycotic aneurysm of the basilar arterycase report. Neurol Med Chir (Tokyo) 1990 30 8 618-623
205. Schwartz S, Ruhnke M, Ribaud P et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 2005 106 8 2641-2645 (Pubitemid 41510735)
206. Radner A B., Witt M D., Edwards J E. Jr. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin Infect Dis 1995 20 1 163-166
207. Press G A., Weindling S M., Hesselink J R., Ochi J W., Harris J P. Rhinocerebral mucormycosis: MR manifestations. J Comput Assist Tomogr 1988 12 5 744-749
208. Calli C, Savas R, Parildar M, Pekindil G, Alper H, Yunten N. Isolated pontine infarction due to rhinocerebral mucormycosis. Neuroradiology 1999 41 3 179-181 (Pubitemid 29126782)
209. Rangel-Guerra R A., Martínez H R., Sáenz C, Bosques-Padilla F, Estrada-Bellmann I. Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases. J Neurol Sci 1996 143 1-2 19-30 (Pubitemid 26402782)
210. Pagano L, Ricci P, Tonso A et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). Br J Haematol 1997 99 2 331-336
211. Escobar A, Del Brutto O H. Multiple brain abscesses from isolated cerebral mucormycosis. J Neurol Neurosurg Psychiatry 1990 53 5 431-433 (Pubitemid 20173282)
212. Cuadrado L M., Guerrero A, Garcia Asenjo J A., Martin F, Palau E, Garcia Urra D. Cerebral mucormycosis in two cases of acquired immunodeficiency syndrome. Arch Neurol 1988 45 1 109-111 (Pubitemid 18018596)
213. Hopkins R J., Rothman M, Fiore A, Goldblum S E. Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin Infect Dis 1994 19 6 1133-1137 (Pubitemid 24380030)
214. Zarei M, Morris J, Aachi V, Gregory R, Meanock C, Brito-Babapulle F. Acute isolated cerebral mucormycosis in a patient with high grade non-Hodgkins lymphoma. Eur J Neurol 2000 7 4 443-447 (Pubitemid 32280908)
215. Yousem D M., Galetta S L., Gusnard D A., Goldberg H I. MR findings in rhinocerebral mucormycosis. J Comput Assist Tomogr 1989 13 5 878-882 (Pubitemid 19245085)
216. Galetta S L., Wulc A E., Goldberg H I., Nichols C W., Glaser J S. Rhinocerebral mucormycosis: management and survival after carotid occlusion. Ann Neurol 1990 28 1 103-107 (Pubitemid 20222162)
217. Lazo A, Wilner H I., Metes J J. Craniofacial mucormycosis: computed tomographic and angiographic findings in two cases. Radiology 1981 139 3 623-626 (Pubitemid 11072787)
218. Mischel P S., Vinters H V. Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis 1995 20 2 400-405
219. Mathisen G, Shelub A, Truong J, Wigen C. Coccidioidal meningitis: clinical presentation and management in the fluconazole era. Medicine (Baltimore) 2010 89 5 251-284
220. Sobel R A., Ellis W G., Nielsen S L., Davis R L. Central nervous system coccidioidomycosis: a clinicopathologic study of treatment with and without amphotericin B. Hum Pathol 1984 15 10 980-995 (Pubitemid 15130388)
221. Mathisen G, Shelub A, Truong J, Wigen C. Coccidioidal meningitis: clinical presentation and management in the fluconazole era. Medicine (Baltimore) 2010 89 5 251-284
222. Williams P L., Johnson R, Pappagianis D et al. Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clin Infect Dis 1992 14 3 673-682
223. Arsura E L., Johnson R, Penrose J et al. Neuroimaging as a guide to predict outcomes for patients with coccidioidal meningitis. Clin Infect Dis 2005 40 4 624-627 (Pubitemid 40270238)
224. de Carvalho C A., Allen J N., Zafranis A, Yates A J. Coccidioidal meningitis complicated by cerebral arteritis and infarction. Hum Pathol 1980 11 3 293-296 (Pubitemid 10121174)
225. Johnson R H., Einstein H E. Coccidioidal meningitis. Clin Infect Dis 2006 42 1 103-107 (Pubitemid 41832088)
226. Drake K W., Adam R D. Coccidioidal meningitis and brain abscesses: analysis of 71 cases at a referral center. Neurology 2009 73 21 1780-1786
227. Ragland A S., Arsura E, Ismail Y, Johnson R. Eosinophilic pleocytosis in coccidioidal meningitis: frequency and significance. Am J Med 1993 95 3 254-257 (Pubitemid 23270281)
228. Blair J E., Coakley B, Santelli A C., Hentz J G., Wengenack N L. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia 2006 162 5 317-324 (Pubitemid 44819314)
229. Williams P L. Vasculitic complications associated with coccidioidal meningitis. Semin Respir Infect 2001 16 4 270-279 (Pubitemid 34031650)
230. Galgiani J N., Ampel N M., Blair J E. et al, Infectious Diseases Society of America. Coccidioidomycosis. Clin Infect Dis 2005 41 9 1217-1223 (Pubitemid 41532662)
231. Cortez K J., Walsh T J., Bennett J E. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis 2003 36 12 1619-1622 (Pubitemid 36783349)
232. Wheat L J., Batteiger B E., Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore) 1990 69 4 244-260 (Pubitemid 20225992)
233. Saccente M. Central nervous system histoplasmosis. Curr Treat Options Neurol 2008 10 3 161-167
234. Carod-Artal F J., Venturini M, Gomes E, de Mello M T. [Chronic central nervous system histoplasmosis in an immunocompetent patient]. Neurologia 2008 23 4 263-268 (Pubitemid 351897954)
235. Wheat L J., Musial C E., Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005 40 6 844-852 (Pubitemid 40365505)
236. Mitchell D H., Sorrell T C., Allworth A M. et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995 20 3 611-616
237. Shih C C., Chen Y C., Chang S C., Luh K T., Hsieh W C. Cryptococcal meningitis in non-HIV-infected patients. QJM 2000 93 4 245-251
238. Tjia T L., Yeow Y K., Tan C B. Cryptococcal meningitis. J Neurol Neurosurg Psychiatry 1985 48 9 853-858 (Pubitemid 15021649)
239. Lan S H., Chang W N., Lu C H., Lui C C., Chang H W. Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis. QJM 2001 94 5 247-253
240. Chen S, Sorrell T, Nimmo G et al, Australasian Cryptococcal Study Group. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000 31 2 499-508 (Pubitemid 32289583)
241. Lane M, McBride J, Archer J. Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis. Neurology 2004 63 4 713-714 (Pubitemid 39100832)
242. Saag M S., Graybill R J., Larsen R A. et al, Infectious Diseases Society of America. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000 30 4 710-718
243. Garcia H H., Gonzalez A E., Gilman R H., Cysticerosis Working Group in Peru. Diagnosis, treatment and control of Taenia solium cysticercosis. Curr Opin Infect Dis 2003 16 5 411-419 (Pubitemid 37267260)
244. Alarcón F, Hidalgo F, Moncayo J, Viñán I, Dueñas G. Cerebral cysticercosis and stroke. Stroke 1992 23 2 224-228
245. Del Brutto O H. Cysticercosis and cerebrovascular disease: a review. J Neurol Neurosurg Psychiatry 1992 55 4 252-254
246. Scharf D. Neurocysticercosis. Two hundred thirty-eight cases from a California hospital. Arch Neurol 1988 45 7 777-780
247. Barinagarrementeria F, Cantú C. Frequency of cerebral arteritis in subarachnoid cysticercosis: an angiographic study. Stroke 1998 29 1 123-125 (Pubitemid 28046952)
248. Alarcón F, Vanormelingen K, Moncayo J, Viñán I. Cerebral cysticercosis as a risk factor for stroke in young and middle-aged people. Stroke 1992 23 11 1563-1565
249. Del Brutto O, Barinagarrementeria F. Inflammatory arteriopathies and pure motor hemiplegia. Arch Neurol 1989 46 4 361
250. Rodriguez-Carbajal J, Del Brutto O H., Penagos P, Huebe J, Escobar A. Occlusion of the middle cerebral artery due to cysticercotic angiitis. Stroke 1989 20 8 1095-1099 (Pubitemid 19204027)
251. Cantú C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 1996 53 3 233-239 (Pubitemid 26077475)
252. Patel R, Jha S, Yadav R K. Pleomorphism of the clinical manifestations of neurocysticercosis. Trans R Soc Trop Med Hyg 2006 100 2 134-141 (Pubitemid 43024769)
253. Bouldin A, Pinter J D. Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. J Child Neurol 2006 21 12 1064-1067 (Pubitemid 46128359)
254. Cantú C, Villarreal J, Soto J L., Barinagarrementeria F. Cerebral cysticercotic arteritis: detection and follow-up by transcranial Doppler. Cerebrovasc Dis 1998 8 1 2-7 (Pubitemid 28046069)
255. Viola G M., White A C. Jr, Serpa J A. Hemorrhagic cerebrovascular events and neurocysticercosis: a case report and review of the literature. Am J Trop Med Hyg 2011 84 3 402-405
256. García H H., Evans C AW, Nash T E. et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002 15 4 747-756 (Pubitemid 41184085)